1997
DOI: 10.1074/jbc.272.4.2527
|View full text |Cite
|
Sign up to set email alerts
|

Identification of an Actin Binding Region and a Protein Kinase C Phosphorylation Site on Human Fascin

Abstract: Fascin is a 55-58-kDa actin-bundling protein, the actin binding of which is regulated by phosphorylation (Yamakita, Y., Ono, S., Matsumura, F., and Yamashiro, S. . Second, we identified the phosphorylation site of fascin as Ser-39 by sequencing a tryptic phosphopeptide purified by chelating column chromatography followed by C-18 reverse phase high performance liquid chromatography. Peptide map analyses revealed that the purified peptide represented the major phosphorylation site of in vivo as well as in vitro … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
193
0
1

Year Published

1999
1999
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 171 publications
(197 citation statements)
references
References 39 publications
3
193
0
1
Order By: Relevance
“…Fascin immunoreactivity may thus be considered a more reliable tool for better assessing the biological aggressiveness and clinical course of NSCLC. Furthermore, the inhibition of fascin activity by phosphorylation (Yamakita et al, 1996, Ono et al, 1997, Tilney et al, 1998Adams et al, 1999, Cohan et al, 2001 or antisense oligonucleotide strategy (Al-Alwan et al, 2001) could represent potentially novel therapeutic options in the treatment of lung cancer. The validation of differentially expressed fascin levels in NSCLC could open new diagnostic and therapeutic perspectives, such as the development of radiologic imaging systems based on tagged antibody strategy to detect small lung cancers, either primary or metastatic, or the strategy of cell-mediated or antibody-based immunotherapy using fascin for targeting more aggressive lung carcinomas.…”
Section: Discussionmentioning
confidence: 99%
“…Fascin immunoreactivity may thus be considered a more reliable tool for better assessing the biological aggressiveness and clinical course of NSCLC. Furthermore, the inhibition of fascin activity by phosphorylation (Yamakita et al, 1996, Ono et al, 1997, Tilney et al, 1998Adams et al, 1999, Cohan et al, 2001 or antisense oligonucleotide strategy (Al-Alwan et al, 2001) could represent potentially novel therapeutic options in the treatment of lung cancer. The validation of differentially expressed fascin levels in NSCLC could open new diagnostic and therapeutic perspectives, such as the development of radiologic imaging systems based on tagged antibody strategy to detect small lung cancers, either primary or metastatic, or the strategy of cell-mediated or antibody-based immunotherapy using fascin for targeting more aggressive lung carcinomas.…”
Section: Discussionmentioning
confidence: 99%
“…In either case, the net result would be improper cross-linking by fascin. Interestingly, work from Matsumura's laboratory has shown that whereas phosphorylation by kinases can regulate actin–fascin interactions in vitro (Yamakita et al 1996; Shoichiro et al 1997), the stoichiometry of in vivo phosphorylation is low, suggesting that other mechanisms control fascin–actin interactions under normal conditions. In addition, since only tiny bundles form during staurosporine treatment as assayed either by our phalloidin staining or our thin sections, the forked cross-link may also be affected either directly or indirectly by this drug.…”
Section: Discussionmentioning
confidence: 99%
“…PKC-mediated phosphorylation at serine 39 reduces the actin-bundling activity of fascin, resulting in its disappearance from actin microspikes (Yamakita et al, 1996;Ono et al, 1997). Because PKC activity is influenced to some extent by the rho family GTPases, as a result of their effects on phosphatidylinositol 4,5-bisphosphate metabolism (Stossel, 1993;Chong et al, 1994;Hartwig et al, 1995), engagement of NG2 may alter the level of fascin phosphorylation, resulting in changes in the dynamics of the actinfascin association.…”
Section: Discussionmentioning
confidence: 99%